Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05607732 · ClinicalTrials.gov registry record · NA
Primary Care Detection of Cognitive Impairment Leveraging Health & Consumer Technologies in Underserved Communities: The MyCog Trial
A NA study of Alzheimer Disease and Dementia, sponsored by Northwestern University.
- Recruiting
- Registry status
- NA
- Development phase
- 45,257
- Enrollment target
- 1
- Study location
NCT05607732 is a NA study of Alzheimer Disease and Dementia that is actively recruiting participants, run by Northwestern University. The registered enrollment target is 45,257 participants, above the 2,603-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (1639% higher). The trial reports 1 study location across 1 state.
The verdict
NCT05607732, a NA study of Alzheimer Disease and Dementia, is actively recruiting participants, sponsored by Northwestern University.
- RECRUITING
- Registry status
- NA
- Development phase
- 45,257 participants
- Enrollment target
- 1
- Study location
Study Summary
Our study intends to offer 'real world' evidence of a viable, sustainable means to mobilize primary care via a comprehensive strategy for detecting cognitive impairment and dementias, advancing next steps for referral, and participating in the care planning and management of affected patients and caregivers. We will conduct a clinic-randomized, pragmatic trial testing the effectiveness and fidelity of our NIH Toolbox-derived paradigm to improve early detection and management of cognitive impairment/dementia in primary care settings serving health disparate patient populations.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST MyCog
Study Locations (1)
Illinois
- Oak Street Health - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45,257 participants |
| Start Date | 2024-01-30 |
| Est. Completion | 2027-07-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05607732
The ClinicalTrials.gov registry entry for NCT05607732 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 45,257 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 2,603-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (1639% higher). The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Alzheimer Disease appearing as the primary indexed condition, and to 1 intervention - of which MyCog is the first listed.
NCT05607732 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT05607732 about?
NCT05607732 is a clinical study titled "Primary Care Detection of Cognitive Impairment Leveraging Health & Consumer Technologies in Underserved Communities: The MyCog Trial". Our study intends to offer 'real world' evidence of a viable, sustainable means to mobilize primary care via a comprehensive strategy for detecting cognitive impairment and dementias, advancing next steps for referral, and participating in the care planning and management of affected patients and ca...
What is the current status of trial NCT05607732?
This trial is currently recruiting. It is a NA study. The enrollment target is 45,257 participants. The study started on 2024-01-30. Estimated completion is 2027-07-07.
What conditions does trial NCT05607732 study?
This clinical trial studies the following conditions: Alzheimer Disease, Dementia, Cognitive Impairment, Cognitive Decline.
What interventions are being tested in trial NCT05607732?
The interventions under investigation include: MyCog (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05607732?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05607732 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alzheimer Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
I-CARE 2: Mobile Telehealth to Reduce Alzheimer'S-related Symptoms
RECRUITING · NA
-
Brain Outcomes With Lifestyle Change in Down Syndrome
RECRUITING · NA
-
Pulsed Electromagnetic Field Treatment In Patients With Alzheimer's Disease
RECRUITING · NA
-
A Feasiblity Study of Green Activity Program for People Living With Memory Challenges
RECRUITING · NA
-
Connect-Home: Alzheimer's Disease and Related Dementias
RECRUITING · NA
-
Cognitive Vulnerability to Stress in Individuals at Risk for Alzheimer's Disease
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.